FDA approves diabetes drug with new approach

AZ Central: WASHINGTON (AP) -- The Food and Drug Administration on Wednesday approved a new diabetes drug from Bristol-Myers Squibb and AstraZeneca that uses a novel approach to reduce blood sugar.

Read article